April 18, 2014
5:09 pm

Teva reaches settlement with Pfizer over Celebrex patent

Teva's facility in Har Hotzvim, Jerusalem (photo credit: Nati Shohat/Flash90)

From the web Lawyer Herald: Teva Pharmaceuticals has been seeking to release a generic version of Celebrex, Pfizer's blockbuster painkiller, for years, as the patent for the drug expired. Pfizer tried to extend the patent, but failed -- but still sued Teva and five other companies over the generic versions of the drug. The lawsuit has now been settled, and Teva will be able to release its version of Celebrex by December, according to the terms of the deal

 
Start-Up Israel in your inbox
Get the Start-Up Daily free by email for selected top stories of our 24/7 coverage
Please enter your full name
Please select your country
Almost finished...
We need to confirm your email address first.

To complete the subscription process, please click the link in the email we just sent you.
By signing up to the Start-Up Daily mailing list, you hereby accept The Times of Israel Terms of Use and Privacy Policy, and you agree to receive the latest news & offers from the Start-Up Israel and its partners or ad sponsors.
Currency Rates
  ILS USD EUR GBP CAD
1 ILS = 1.000 0.288 0.208 0.171 0.317
1 USD = 3.474 1.000 0.722 0.594 1.100
1 EUR = 4.810 1.385 1.000 0.823 1.524
1 GBP = 5.848 1.683 1.216 1.000 1.852
1 CAD = 3.157 0.909 0.656 0.540 1.000
Bank of Israel exchange rates for Thursday, Apr 17, 2014
Back to Top